EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Importance of the Cysteine-Rich Domain of Snake Venom Prothrombin Activators: Insights Gained from Synthetic Neutralizing Antibodies

Laetitia E Misson Mindrebo iD, Jeffrey T Mindrebo, Quoc Tran iD, Mark C Wilkinson, Jessica M Smith iD, Megan Verma, Nicholas R Casewell iD, Gabriel C Lander iD, Joseph G Jardine iD

Toxins · 2024

DOI: 10.3390/toxins16080361 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxins, 2024. Verfasst von Laetitia E Misson Mindrebo und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, Prothrombin. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: U.K. Foreign Commonwealth & Development Office, NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Snake venoms are cocktails of biologically active molecules that have evolved to immobilize prey, but can also induce a severe pathology in humans that are bitten. While animal-derived polyclonal antivenoms are the primary treatment for snakebites, they often have limitations in efficacy and can cause severe adverse side effects. Building on recent efforts to develop improved antivenoms, notably through monoclonal antibodies, requires a comprehensive understanding of venom toxins. Among these toxins, snake venom metalloproteinases (SVMPs) play a pivotal role, particularly in viper envenomation, causing tissue damage, hemorrhage and coagulation disruption. One of the current challenges in the development of neutralizing monoclonal antibodies against SVMPs is the large size of the protein and the lack of existing knowledge of neutralizing epitopes. Here, we screened a synthetic human antibody library to isolate monoclonal antibodies against an SVMP from saw-scaled viper (genus Echis) venom. Upon characterization, several antibodies were identified that effectively blocked SVMP-mediated prothrombin activation. Cryo-electron microscopy revealed the structural basis of antibody-mediated neutralization, pinpointing the non-catalytic cysteine-rich domain of SVMPs as a crucial target. These findings emphasize the importance of understanding the molecular mechanisms of SVMPs to counter their toxic effects, thus advancing the development of more effective antivenoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, NeutralizingProthrombinAnimalsHumansAntiveninsViper VenomsCysteineAntibodies, MonoclonalMetalloproteasesProtein DomainsViperidae

Stichwörter der Autor:innen

Echiscysteine-rich domainecarin structureneutralizing antibodyprothrombin activatorrecombinant antivenomsnake venom metalloproteinases

Substanzen

Antibodies, NeutralizingProthrombinAntiveninsViper VenomsCysteineAntibodies, MonoclonalMetalloproteases

Autor:innen und Institutionen

  • Department of Immunology and Microbiology, Scripps Research Institute, La Jolla, CA 92037, USA.
  • IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA 92037, USA.
  • International AIDS Vaccine Initiative, New York, NY 10004, USA.
  • Department of Integrative Structural and Computational Biology, Scripps Research Institute, La Jolla, CA 92037, USA.
  • Centre for Snakebite Research & Interventions, Department of Tropical Disease Biology, Liverpool School of Tropical Medicine, Liverpool L3 5QA, UK.

ORCID-Profile: Laetitia E Misson Mindrebo, Quoc Tran, Jessica M Smith, Nicholas R Casewell, Gabriel C Lander, Joseph G Jardine

Förderung

  • U.K. Foreign Commonwealth & Development Office
  • NIH HHS
  • NIGMS NIH HHS
  • Wellcome Trust
  • NINDS NIH HHS
  • National Institutes of Health (NIH)
  • U.K. Foreign Commonwealth & Development Office

Zitieren

APA

Misson Mindrebo, L. E., Mindrebo, J. T., Tran, Q., Wilkinson, M. C., Smith, J. M., Verma, M., Casewell, N. R., Lander, G. C., & Jardine, J. G. (2024). Importance of the Cysteine-Rich Domain of Snake Venom Prothrombin Activators: Insights Gained from Synthetic Neutralizing Antibodies. Toxins. https://doi.org/10.3390/toxins16080361

Vancouver

Misson Mindrebo LE, Mindrebo JT, Tran Q, Wilkinson MC, Smith JM, Verma M, et al. Importance of the Cysteine-Rich Domain of Snake Venom Prothrombin Activators: Insights Gained from Synthetic Neutralizing Antibodies. Toxins. 2024. doi:10.3390/toxins16080361

BibTeX
@article{MissonMindrebo2024,
  author = {Misson Mindrebo, Laetitia E and Mindrebo, Jeffrey T and Tran, Quoc and Wilkinson, Mark C and Smith, Jessica M and Verma, Megan and Casewell, Nicholas R and Lander, Gabriel C and Jardine, Joseph G},
  title = {Importance of the Cysteine-Rich Domain of Snake Venom Prothrombin Activators: Insights Gained from Synthetic Neutralizing Antibodies},
  journal = {Toxins},
  year = {2024},
  doi = {10.3390/toxins16080361}
}
Kostenlos starten →